{"id":68793,"date":"2013-08-28T11:13:03","date_gmt":"2013-08-28T10:13:03","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=2847"},"modified":"2013-08-28T11:13:03","modified_gmt":"2013-08-28T10:13:03","slug":"les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/","title":{"rendered":"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics"},"content":{"rendered":"<p><strong>El Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya (CCFC) i el CatSalut estan definint un<\/strong> <strong>pla pilot per poder fer un seguiment des de les farm\u00e0cies de l\u2019evoluci\u00f3 de pacients cr\u00f2nics complexos<\/strong>. Es tracta de pacients amb un historial de freq\u00fcents ingressos hospitalaris, que pateixen patologies simult\u00e0nies i amb una adher\u00e8ncia a les ter\u00e0pies que no \u00e9s \u00f2ptima. El metge d\u2019atenci\u00f3 prim\u00e0ria ser\u00e0 qui, si ho veu oport\u00fa, derivar\u00e0 al pacient a la seva farm\u00e0cia de refer\u00e8ncia.<\/p>\n<p><strong><img fetchpriority=\"high\" decoding=\"async\" class=\"alignleft\" alt=\"spd\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/08\/spd.jpg\" width=\"306\" height=\"204\" \/><\/strong>El paper del farmac\u00e8utic es centrar\u00e0 en realitzar el <strong>seguiment farmacoterap\u00e8utic<\/strong> per controlar que la medicaci\u00f3 es pren adequadament i en la preparaci\u00f3 de sistemes personalitzats de dosificaci\u00f3 (SPD). Els farmac\u00e8utics que hi participin estaran autoritzats per prestar aquest servei i es formaran en l\u2019atenci\u00f3 a aquest tipus de pacients complexos.<\/p>\n<p>Pilar Gasc\u00f3n, secret\u00e0ria del Consell i tamb\u00e9 vocal d\u2019Investigaci\u00f3 i Doc\u00e8ncia del Col\u00b7legi de Farmac\u00e8utics de Barcelona, ha comentat que la prova pilot segueix en la l\u00ednia de l\u2019objectiu per part del col\u00b7lectiu de \u201cfer <strong>noves actuacions professionals fonamentades en el coneixement dels medicaments del farmac\u00e8utic per tal que els pacients obtinguin el m\u00e0xim benefici dels tractaments<\/strong> que segueixen\u201d.<\/p>\n<p>La prova pilot per comprovar la viabilitat del projecte s\u2019iniciar\u00e0 previsiblement abans de finalitzar l\u2019any 2013.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya (CCFC) i el CatSalut estan definint un pla pilot per poder fer un seguiment des de les farm\u00e0cies de l\u2019evoluci\u00f3 de pacients cr\u00f2nics complexos. Es tracta de pacients amb un historial de freq\u00fcents ingressos hospitalaris, que pateixen patologies simult\u00e0nies i amb una adher\u00e8ncia [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2853,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,32],"tags":[64,147],"class_list":["post-68793","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-noticies-farmacia","tag-atencio-farmaceutica","tag-medicament"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya (CCFC) i el CatSalut estan definint un pla pilot per poder fer un seguiment des de les farm\u00e0cies de l\u2019evoluci\u00f3 de pacients cr\u00f2nics complexos. Es tracta de pacients amb un historial de freq\u00fcents ingressos hospitalaris, que pateixen patologies simult\u00e0nies i amb una adher\u00e8ncia [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-08-28T10:13:03+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics\",\"datePublished\":\"2013-08-28T10:13:03+00:00\",\"dateModified\":\"2013-08-28T10:13:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\"},\"wordCount\":241,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"Medicament\"],\"articleSection\":[\"Destacats\",\"Not\u00edcies farm\u00e0cia\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\",\"name\":\"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2013-08-28T10:13:03+00:00\",\"dateModified\":\"2013-08-28T10:13:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/","og_locale":"ca_ES","og_type":"article","og_title":"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya (CCFC) i el CatSalut estan definint un pla pilot per poder fer un seguiment des de les farm\u00e0cies de l\u2019evoluci\u00f3 de pacients cr\u00f2nics complexos. Es tracta de pacients amb un historial de freq\u00fcents ingressos hospitalaris, que pateixen patologies simult\u00e0nies i amb una adher\u00e8ncia [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2013-08-28T10:13:03+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics","datePublished":"2013-08-28T10:13:03+00:00","dateModified":"2013-08-28T10:13:03+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/"},"wordCount":241,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 farmac\u00e8utica","Medicament"],"articleSection":["Destacats","Not\u00edcies farm\u00e0cia"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/","url":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/","name":"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage"},"thumbnailUrl":"","datePublished":"2013-08-28T10:13:03+00:00","dateModified":"2013-08-28T10:13:03+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":1,"uagb_excerpt":"El Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya (CCFC) i el CatSalut estan definint un pla pilot per poder fer un seguiment des de les farm\u00e0cies de l\u2019evoluci\u00f3 de pacients cr\u00f2nics complexos. Es tracta de pacients amb un historial de freq\u00fcents ingressos hospitalaris, que pateixen patologies simult\u00e0nies i amb una adher\u00e8ncia [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/68793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=68793"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/68793\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=68793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=68793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=68793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}